• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


ZLD Results of Meeting17/09/20 download Created with Sketch. 216.29KB
ZLD Zenivol launches in Australia after TGA approves releasePRICE SENSITIVE16/09/20 download Created with Sketch. 201.99KB
ZLD Appendix 3G11/09/20 download Created with Sketch. 320.83KB
ZLD Issue of Unquoted Options11/09/20 download Created with Sketch. 147.02KB
ZLD Zelira Presentation ASX Small and Mid-Cap Conference10/09/20 download Created with Sketch. 4.32MB
ZLD Zelira Forms Subsidiary to Launch Oral Care Products in USAPRICE SENSITIVE08/09/20 download Created with Sketch. 195.96KB
ZLD Appendix 4G28/08/20 download Created with Sketch. 162.16KB
ZLD Appendix 4E & Financial StatementsPRICE SENSITIVE28/08/20 download Created with Sketch. 1.37MB
ZLD HOPE Range Of Products Launches In LouisianaPRICE SENSITIVE20/08/20 download Created with Sketch. 180.23KB
ZLD Ceasing to be a substantial holder14/08/20 download Created with Sketch. 230.2KB
ZLD Change in substantial holding14/08/20 download Created with Sketch. 160.53KB
ZLD Change of Director's Interest Notice x214/08/20 download Created with Sketch. 252.52KB
ZLD Notice of General Meeting13/08/20 download Created with Sketch. 201.07KB
ZLD Letter to Shareholders re Upcoming General Meeting13/08/20 download Created with Sketch. 167.25KB
ZLD Appendix 3G11/08/20 download Created with Sketch. 319.74KB
ZLD Cleansing Notice and Appendix 2A11/08/20 download Created with Sketch. 601.79KB
ZLD Proposed issue of Securities - ZLD03/08/20 download Created with Sketch. 25.16KB
ZLD ZLD Successfully Completes $8.75M Oversubscribed PlacementPRICE SENSITIVE03/08/20 download Created with Sketch. 152.46KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/07/20 download Created with Sketch. 156.45KB
ZLD June 2020 Quarterly ReportPRICE SENSITIVE30/07/20 download Created with Sketch. 245.26KB
ZLD Trading HaltPRICE SENSITIVE29/07/20 download Created with Sketch. 581.11KB
ZLD Zelira Enters Deal to Develop Products For Vascular DiseasesPRICE SENSITIVE22/07/20 download Created with Sketch. 224.23KB
ZLD Results of Meeting21/07/20 download Created with Sketch. 254.05KB
ZLD Trading HaltPRICE SENSITIVE20/07/20 download Created with Sketch. 365.35KB
ZLD Zelira Phase 1 Chronic Pain Trial Meets Clinical EndpointsPRICE SENSITIVE14/07/20 download Created with Sketch. 288.01KB
ZLD Proposed issue of Securities - ZLD10/07/20 download Created with Sketch. 25.61KB
ZLD Director Performance Rights10/07/20 download Created with Sketch. 152.67KB
ZLD Investor Presentation - Non-deal Roadshow09/07/20 download Created with Sketch. 4.84MB
ZLD Proposed issue of Securities - ZLD17/06/20 download Created with Sketch. 41.3KB
ZLD Notice of General Meeting17/06/20 download Created with Sketch. 307.1KB
ZLD Letter to Shareholders17/06/20 download Created with Sketch. 166.56KB
ZLD ZLD to form partnership for chronic pain in retired athletes17/06/20 download Created with Sketch. 233.21KB
ZLD Finalisation of Appointment Details - Managing Director, USA03/06/20 download Created with Sketch. 198.17KB
ZLD TasAlk to Manufacture Zeliras Insomnia and HOPE productsPRICE SENSITIVE26/05/20 download Created with Sketch. 155.63KB
ZLD Investor Presentation - Non-deal Roadshow01/05/20 download Created with Sketch. 5.08MB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/04/20 download Created with Sketch. 167.78KB
ZLD March 2020 Quarterly ReportPRICE SENSITIVE30/04/20 download Created with Sketch. 162.06KB
ZLD Insomnia Phase 2 Clinical Trial Presentation08/04/20 download Created with Sketch. 3.09MB
ZLD Zelira Therapeutics Insomnia Clinical Trial Media Release07/04/20 download Created with Sketch. 307.83KB
ZLD Insomnia Trial Meets Primary and Secondary EndpointsPRICE SENSITIVE07/04/20 download Created with Sketch. 682.01KB
ZLD Appendix 4D & FY20 Interim Financial ReportPRICE SENSITIVE28/02/20 download Created with Sketch. 995.62KB
ZLD EMD: EMD to Conduct Opioid Sparing Clinical Trial for Zelira27/02/20 download Created with Sketch. 195.36KB
ZLD Phase 1 Opioid Reduction Clinical Trial Fully EnrolledPRICE SENSITIVE27/02/20 download Created with Sketch. 160.74KB
ZLD Appendix 2A and Cleansing Notice19/02/20 download Created with Sketch. 478.66KB
ZLD Zelira Meets Primary Endpoints for Insomnia TrialPRICE SENSITIVE19/02/20 download Created with Sketch. 275.92KB
ZLD Trading HaltPRICE SENSITIVE17/02/20 download Created with Sketch. 228.76KB
ZLD Proposed issue of Securities - ZLD17/02/20 download Created with Sketch. 24.98KB
ZLD Capital Raising Update17/02/20 download Created with Sketch. 119.62KB
ZLD Expiry of unlisted options07/02/20 download Created with Sketch. 110.26KB
ZLD Cleansing Notice06/02/20 download Created with Sketch. 198.8KB
ZLD Appendix 2A06/02/20 download Created with Sketch. 273.82KB
ZLD Proposed issue of Securities - ZLD05/02/20 download Created with Sketch. 25.23KB
ZLD Zelira Successfully Completes Capital Raising of $4.6MPRICE SENSITIVE05/02/20 download Created with Sketch. 161.73KB
ZLD Trading HaltPRICE SENSITIVE03/02/20 download Created with Sketch. 192.45KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/01/20 download Created with Sketch. 207.02KB
ZLD December 2019 Quarterly ReportPRICE SENSITIVE31/01/20 download Created with Sketch. 126.51KB
ZLD Zelira to Collaborate with the Parkinsons FoundationPRICE SENSITIVE28/01/20 download Created with Sketch. 163.61KB
ZLD Ceasing to be a substantial holder17/01/20 download Created with Sketch. 150.39KB
ZLD Change in substantial holding10/01/20 download Created with Sketch. 386.3KB
ZLD Change of Director's Interest Notice x 302/01/20 download Created with Sketch. 250.96KB
ZLD Appendix 3B and Cleansing Notice02/01/20 download Created with Sketch. 478.06KB
ZLD Notification of Expiry of Unlisted Options02/01/20 download Created with Sketch. 173.61KB
ZLD Change of Director's Interest Notice x 323/12/19 download Created with Sketch. 304.66KB
ZLD Appendix 3B23/12/19 download Created with Sketch. 437.09KB
ZLD Last patient completes dosing in insomnia clinical trial17/12/19 download Created with Sketch. 133.56KB
ZLD Official name change to Zelira Therapeutics04/12/19 download Created with Sketch. 102.5KB
ZLD Initial Director's Interest Notice x 304/12/19 download Created with Sketch. 171.19KB
ZLD Zelira Therapeutics expands HOPE distribution in the U.S.APRICE SENSITIVE04/12/19 download Created with Sketch. 139.89KB
ZLD Final Director's Interest Notice02/12/19 download Created with Sketch. 210.27KB
ZLD Ilera Therapeutics Merger Completed and Board ChangesPRICE SENSITIVE02/12/19 download Created with Sketch. 165.2KB
ZLD New Constitution28/11/19 download Created with Sketch. 664.74KB
ZLD Results of Meeting28/11/19 download Created with Sketch. 223.04KB
ZLD 2019 AGM Chairman's Address28/11/19 download Created with Sketch. 110.83KB
ZLD Annual General Meeting Presentation 201928/11/19 download Created with Sketch. 6.37MB
ZLD Investor Presentation - Non-deal Roadshow25/11/19 download Created with Sketch. 6.35MB
ZLD Agreement with Health House to Distribute Zelda ProductsPRICE SENSITIVE21/11/19 download Created with Sketch. 212.12KB
ZLD Update on Global Launch Strategy for HOPE Range of Products20/11/19 download Created with Sketch. 136.88KB
ZLD Formulations to be supplied as part of CARE NSW trialPRICE SENSITIVE14/11/19 download Created with Sketch. 160.54KB
ZLD R&D Tax Incentive RefundPRICE SENSITIVE11/11/19 download Created with Sketch. 108.66KB
ZLD Zeldas Phase II Insomnia Clinical Trial Fully EnrolledPRICE SENSITIVE07/11/19 download Created with Sketch. 175.64KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/10/19 download Created with Sketch. 203.39KB
ZLD September 2019 Quarterly ReportPRICE SENSITIVE31/10/19 download Created with Sketch. 167.65KB
ZLD Notice of Annual General Meeting25/10/19 download Created with Sketch. 435.62KB
ZLD Becoming a substantial holder16/10/19 download Created with Sketch. 259.8KB
ZLD Zelira Transaction Investor Teleconference and Q&A15/10/19 download Created with Sketch. 172.89KB
ZLD Appendix 3B and Cleansing Notice10/10/19 download Created with Sketch. 649.03KB
ZLD Investor Presentation - Zelira - Non Deal Roadshow09/10/19 download Created with Sketch. 9.72MB
ZLD Zelda to merge with US-based Ilera TherapeuticsPRICE SENSITIVE09/10/19 download Created with Sketch. 223.68KB
ZLD Trading HaltPRICE SENSITIVE08/10/19 download Created with Sketch. 409.99KB
ZLD Pause in TradingPRICE SENSITIVE08/10/19 download Created with Sketch. 117.26KB
ZLD Appendix 3B27/09/19 download Created with Sketch. 370.57KB
ZLD Cancellation of Unlisted Options02/09/19 download Created with Sketch. 152.08KB
ZLD Appendix 4G30/08/19 download Created with Sketch. 161.13KB
ZLD Appendix 4E & Financial StatementsPRICE SENSITIVE30/08/19 download Created with Sketch. 1.81MB
ZLD Zeldas Autism Observational Study Recruits 100th ParticipantPRICE SENSITIVE22/08/19 download Created with Sketch. 135KB
ZLD June 2019 Quarterly ReportPRICE SENSITIVE31/07/19 download Created with Sketch. 154.04KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/07/19 download Created with Sketch. 203.12KB
ZLD US Non-deal Roadshow - Investor Presentation22/07/19 download Created with Sketch. 11.92MB
ZLD Appendix 3B and Cleansing Notice - Exercise of Options19/07/19 download Created with Sketch. 516KB
ZLD Zelda Collaborates with Emerald ClinicsPRICE SENSITIVE18/07/19 download Created with Sketch. 168.44KB
ZLD Results of Meeting
17/09/20 download Created with Sketch. 216.29KB
ZLD Zenivol launches in Australia after TGA approves release
16/09/20PRICE SENSITIVE download Created with Sketch. 201.99KB
ZLD Appendix 3G
11/09/20 download Created with Sketch. 320.83KB
ZLD Issue of Unquoted Options
11/09/20 download Created with Sketch. 147.02KB
ZLD Zelira Presentation ASX Small and Mid-Cap Conference
10/09/20 download Created with Sketch. 4.32MB
ZLD Zelira Forms Subsidiary to Launch Oral Care Products in USA
08/09/20PRICE SENSITIVE download Created with Sketch. 195.96KB
ZLD Appendix 4G
28/08/20 download Created with Sketch. 162.16KB
ZLD Appendix 4E & Financial Statements
28/08/20PRICE SENSITIVE download Created with Sketch. 1.37MB
ZLD HOPE Range Of Products Launches In Louisiana
20/08/20PRICE SENSITIVE download Created with Sketch. 180.23KB
ZLD Ceasing to be a substantial holder
14/08/20 download Created with Sketch. 230.2KB
ZLD Change in substantial holding
14/08/20 download Created with Sketch. 160.53KB
ZLD Change of Director's Interest Notice x2
14/08/20 download Created with Sketch. 252.52KB
ZLD Notice of General Meeting
13/08/20 download Created with Sketch. 201.07KB
ZLD Letter to Shareholders re Upcoming General Meeting
13/08/20 download Created with Sketch. 167.25KB
ZLD Appendix 3G
11/08/20 download Created with Sketch. 319.74KB
ZLD Cleansing Notice and Appendix 2A
11/08/20 download Created with Sketch. 601.79KB
ZLD Proposed issue of Securities - ZLD
03/08/20 download Created with Sketch. 25.16KB
ZLD ZLD Successfully Completes $8.75M Oversubscribed Placement
03/08/20PRICE SENSITIVE download Created with Sketch. 152.46KB
ZLD Appendix 4C - quarterly
30/07/20PRICE SENSITIVE download Created with Sketch. 156.45KB
ZLD June 2020 Quarterly Report
30/07/20PRICE SENSITIVE download Created with Sketch. 245.26KB
ZLD Trading Halt
29/07/20PRICE SENSITIVE download Created with Sketch. 581.11KB
ZLD Zelira Enters Deal to Develop Products For Vascular Diseases
22/07/20PRICE SENSITIVE download Created with Sketch. 224.23KB
ZLD Results of Meeting
21/07/20 download Created with Sketch. 254.05KB
ZLD Trading Halt
20/07/20PRICE SENSITIVE download Created with Sketch. 365.35KB
ZLD Zelira Phase 1 Chronic Pain Trial Meets Clinical Endpoints
14/07/20PRICE SENSITIVE download Created with Sketch. 288.01KB
ZLD Proposed issue of Securities - ZLD
10/07/20 download Created with Sketch. 25.61KB
ZLD Director Performance Rights
10/07/20 download Created with Sketch. 152.67KB
ZLD Investor Presentation - Non-deal Roadshow
09/07/20 download Created with Sketch. 4.84MB
ZLD Proposed issue of Securities - ZLD
17/06/20 download Created with Sketch. 41.3KB
ZLD Notice of General Meeting
17/06/20 download Created with Sketch. 307.1KB
ZLD Letter to Shareholders
17/06/20 download Created with Sketch. 166.56KB
ZLD ZLD to form partnership for chronic pain in retired athletes
17/06/20 download Created with Sketch. 233.21KB
ZLD Finalisation of Appointment Details - Managing Director, USA
03/06/20 download Created with Sketch. 198.17KB
ZLD TasAlk to Manufacture Zeliras Insomnia and HOPE products
26/05/20PRICE SENSITIVE download Created with Sketch. 155.63KB
ZLD Investor Presentation - Non-deal Roadshow
01/05/20 download Created with Sketch. 5.08MB
ZLD Appendix 4C - quarterly
30/04/20PRICE SENSITIVE download Created with Sketch. 167.78KB
ZLD March 2020 Quarterly Report
30/04/20PRICE SENSITIVE download Created with Sketch. 162.06KB
ZLD Insomnia Phase 2 Clinical Trial Presentation
08/04/20 download Created with Sketch. 3.09MB
ZLD Zelira Therapeutics Insomnia Clinical Trial Media Release
07/04/20 download Created with Sketch. 307.83KB
ZLD Insomnia Trial Meets Primary and Secondary Endpoints
07/04/20PRICE SENSITIVE download Created with Sketch. 682.01KB
ZLD Appendix 4D & FY20 Interim Financial Report
28/02/20PRICE SENSITIVE download Created with Sketch. 995.62KB
ZLD EMD: EMD to Conduct Opioid Sparing Clinical Trial for Zelira
27/02/20 download Created with Sketch. 195.36KB
ZLD Phase 1 Opioid Reduction Clinical Trial Fully Enrolled
27/02/20PRICE SENSITIVE download Created with Sketch. 160.74KB
ZLD Appendix 2A and Cleansing Notice
19/02/20 download Created with Sketch. 478.66KB
ZLD Zelira Meets Primary Endpoints for Insomnia Trial
19/02/20PRICE SENSITIVE download Created with Sketch. 275.92KB
ZLD Trading Halt
17/02/20PRICE SENSITIVE download Created with Sketch. 228.76KB
ZLD Proposed issue of Securities - ZLD
17/02/20 download Created with Sketch. 24.98KB
ZLD Capital Raising Update
17/02/20 download Created with Sketch. 119.62KB
ZLD Expiry of unlisted options
07/02/20 download Created with Sketch. 110.26KB
ZLD Cleansing Notice
06/02/20 download Created with Sketch. 198.8KB
ZLD Appendix 2A
06/02/20 download Created with Sketch. 273.82KB
ZLD Proposed issue of Securities - ZLD
05/02/20 download Created with Sketch. 25.23KB
ZLD Zelira Successfully Completes Capital Raising of $4.6M
05/02/20PRICE SENSITIVE download Created with Sketch. 161.73KB
ZLD Trading Halt
03/02/20PRICE SENSITIVE download Created with Sketch. 192.45KB
ZLD Appendix 4C - quarterly
31/01/20PRICE SENSITIVE download Created with Sketch. 207.02KB
ZLD December 2019 Quarterly Report
31/01/20PRICE SENSITIVE download Created with Sketch. 126.51KB
ZLD Zelira to Collaborate with the Parkinsons Foundation
28/01/20PRICE SENSITIVE download Created with Sketch. 163.61KB
ZLD Ceasing to be a substantial holder
17/01/20 download Created with Sketch. 150.39KB
ZLD Change in substantial holding
10/01/20 download Created with Sketch. 386.3KB
ZLD Change of Director's Interest Notice x 3
02/01/20 download Created with Sketch. 250.96KB
ZLD Appendix 3B and Cleansing Notice
02/01/20 download Created with Sketch. 478.06KB
ZLD Notification of Expiry of Unlisted Options
02/01/20 download Created with Sketch. 173.61KB
ZLD Change of Director's Interest Notice x 3
23/12/19 download Created with Sketch. 304.66KB
ZLD Appendix 3B
23/12/19 download Created with Sketch. 437.09KB
ZLD Last patient completes dosing in insomnia clinical trial
17/12/19 download Created with Sketch. 133.56KB
ZLD Official name change to Zelira Therapeutics
04/12/19 download Created with Sketch. 102.5KB
ZLD Initial Director's Interest Notice x 3
04/12/19 download Created with Sketch. 171.19KB
ZLD Zelira Therapeutics expands HOPE distribution in the U.S.A
04/12/19PRICE SENSITIVE download Created with Sketch. 139.89KB
ZLD Final Director's Interest Notice
02/12/19 download Created with Sketch. 210.27KB
ZLD Ilera Therapeutics Merger Completed and Board Changes
02/12/19PRICE SENSITIVE download Created with Sketch. 165.2KB
ZLD New Constitution
28/11/19 download Created with Sketch. 664.74KB
ZLD Results of Meeting
28/11/19 download Created with Sketch. 223.04KB
ZLD 2019 AGM Chairman's Address
28/11/19 download Created with Sketch. 110.83KB
ZLD Annual General Meeting Presentation 2019
28/11/19 download Created with Sketch. 6.37MB
ZLD Investor Presentation - Non-deal Roadshow
25/11/19 download Created with Sketch. 6.35MB
ZLD Agreement with Health House to Distribute Zelda Products
21/11/19PRICE SENSITIVE download Created with Sketch. 212.12KB
ZLD Update on Global Launch Strategy for HOPE Range of Products
20/11/19 download Created with Sketch. 136.88KB
ZLD Formulations to be supplied as part of CARE NSW trial
14/11/19PRICE SENSITIVE download Created with Sketch. 160.54KB
ZLD R&D Tax Incentive Refund
11/11/19PRICE SENSITIVE download Created with Sketch. 108.66KB
ZLD Zeldas Phase II Insomnia Clinical Trial Fully Enrolled
07/11/19PRICE SENSITIVE download Created with Sketch. 175.64KB
ZLD Appendix 4C - quarterly
31/10/19PRICE SENSITIVE download Created with Sketch. 203.39KB
ZLD September 2019 Quarterly Report
31/10/19PRICE SENSITIVE download Created with Sketch. 167.65KB
ZLD Notice of Annual General Meeting
25/10/19 download Created with Sketch. 435.62KB
ZLD Becoming a substantial holder
16/10/19 download Created with Sketch. 259.8KB
ZLD Zelira Transaction Investor Teleconference and Q&A
15/10/19 download Created with Sketch. 172.89KB
ZLD Appendix 3B and Cleansing Notice
10/10/19 download Created with Sketch. 649.03KB
ZLD Investor Presentation - Zelira - Non Deal Roadshow
09/10/19 download Created with Sketch. 9.72MB
ZLD Zelda to merge with US-based Ilera Therapeutics
09/10/19PRICE SENSITIVE download Created with Sketch. 223.68KB
ZLD Trading Halt
08/10/19PRICE SENSITIVE download Created with Sketch. 409.99KB
ZLD Pause in Trading
08/10/19PRICE SENSITIVE download Created with Sketch. 117.26KB
ZLD Appendix 3B
27/09/19 download Created with Sketch. 370.57KB
ZLD Cancellation of Unlisted Options
02/09/19 download Created with Sketch. 152.08KB
ZLD Appendix 4G
30/08/19 download Created with Sketch. 161.13KB
ZLD Appendix 4E & Financial Statements
30/08/19PRICE SENSITIVE download Created with Sketch. 1.81MB
ZLD Zeldas Autism Observational Study Recruits 100th Participant
22/08/19PRICE SENSITIVE download Created with Sketch. 135KB
ZLD June 2019 Quarterly Report
31/07/19PRICE SENSITIVE download Created with Sketch. 154.04KB
ZLD Appendix 4C - quarterly
31/07/19PRICE SENSITIVE download Created with Sketch. 203.12KB
ZLD US Non-deal Roadshow - Investor Presentation
22/07/19 download Created with Sketch. 11.92MB
ZLD Appendix 3B and Cleansing Notice - Exercise of Options
19/07/19 download Created with Sketch. 516KB
ZLD Zelda Collaborates with Emerald Clinics
18/07/19PRICE SENSITIVE download Created with Sketch. 168.44KB
(20min delay)
Last
6.6¢
Change
0.002(3.13%)
Mkt cap ! $75.39M
Open High Low Value Volume
6.4¢ 6.8¢ 6.3¢ $234.2K 3.547M

Buyers (Bids)

No. Vol. Price($)
5 123880 6.5¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 288756 1
View Market Depth
Last trade - 16.10pm 18/09/2020 (20 minute delay) ?
(live)
Last
6.5¢
  Change
0.002 ( 1.56 %)
Open High Low Volume
6.6¢ 6.8¢ 6.5¢ 446251
Last updated 15.36pm 18/09/2020 (live) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.